Brownstone Journal

Brownstone Journal features in-depth articles, news, research, and commentary on public health, science, economics, social theory, and related policy issues — offering critical perspectives on institutional failures, government interventions, and threats to liberty.

Explore topics like vaccine trials, post-pandemic public sentiment, cancer screening dilemmas, weight loss drugs, food systems, digital ID, antidepressants, pandemic profit motives, collapse in public trust, and paths to evidence-based reform, personal freedoms, and a healthier society.

All Brownstone Institute articles are translated into multiple languages to reach global readers, foster international dialogue, and support challenges to centralized narratives worldwide.

Brownstone Institute » Brownstone Journal
The Army ROTC Taught Me to Never Call Independence Day ‘The 4th of July’

The Army ROTC Taught Me to Never Call Independence Day ‘The 4th of July’

SHARE | PRINT | EMAIL

America was founded on a set of beliefs and convictions—what Thomas Jefferson described as self-evident truths that were proclaimed in the 1776 Declaration of Independence and then protected by the Bill of Rights and the Constitution.

The Army ROTC Taught Me to Never Call Independence Day ‘The 4th of July’ Continue Reading

Accountability for the Vaccine-Injured: A Senator Steps Up

Accountability for the Vaccine-Injured: A Senator Steps Up

SHARE | PRINT | EMAIL

That may become Senator Johnson’s greatest contribution, not simply exposing what happened, but demonstrating that the search for truth does not end when the headlines fade. For thousands of Americans, that renewed faith may prove to be the best medicine of all.

Accountability for the Vaccine-Injured: A Senator Steps Up Continue Reading

FDA Leadership’s “Blind Spots” Leads to a Surge in Medical Device and Drug Recalls

FDA Leadership’s “Blind Spots” Lead to a Surge in Medical Device and Drug Recalls

SHARE | PRINT | EMAIL

The FDA possesses the legal authority, institutional framework, and technical expertise necessary to solve this problem. What is missing is leadership’s willingness to demand the standards that once defined American drug regulation and legacy records of a low number of recalls.

FDA Leadership’s “Blind Spots” Lead to a Surge in Medical Device and Drug Recalls Continue Reading

Join 30,000+ Independent Readers: Get the FREE Brownstone Journal Newsletter